SEC Form 4 · accession 0001179110-16-029280
MEDICINES CO /DE · MDCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen M Rodin
Officer — EVP and General Counsel
Period of report
Aug 31, 2016
Accepted (ET)
Sep 2, 2016 · 5:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113481
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 31, 2016 | A | 378 | $28.08 | A | 17,580 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Acquired pursuant to The Medicines Company Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period beginning March 1, 2016 and ending August 31, 2016. In accordance with the terms of the ESPP, these shares were purchased based on 85% of the fair market value closing price of the issuer's common stock on March 1, 2016.